Showing results (421-430 of 679) with videos related to
Sort By:
Pageof 68
International Journal of Cancer|September 10, 2005
Promoter hypermethylation of the potential tumor suppressor DAL-1/4.1B gene in renal clear cell carcinomaDaisuke Yamada, Shinji Kikuchi, Yuko N Williams, et al.The Journal of Biological Chemistry|December 13, 2016
A Novel Rac1-GSPT1 Signaling Pathway Controls Astrogliosis Following Central Nervous System InjuryTaiji Ishii, Takehiko Ueyama, Michiko Shigyo, et al.Cancer Research|February 4, 2010
The neurofibromatosis type 1 tumor suppressor controls cell growth by regulating signal transducer and activator of transcription-3 activity in vitro and in vivoSutapa Banerjee, Jonathan N Byrd, Scott M Gianino, et al.Acta Neuropathologica|May 10, 2016
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summaryDavid N Louis, Arie Perry, Guido Reifenberger, et al.Journal of Negative Results in Biomedicine|June 2, 2011
Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohortsDavid W Ellison, Mehmet Kocak, Dominique Figarella-Branger, et al.Plos One|December 15, 2015
Correction: Molecular Heterogeneity in a Patient-Derived Glioblastoma Xenoline is Regulated by Different Cancer Stem Cell PopulationsJo Meagan Garner, David W Ellison, David Finkelstein, et al.Neuro-Oncology|March 30, 2019
EZHIP/CXorf67 mimics K27M mutated oncohistones and functions as an intrinsic inhibitor of PRC2 function in aggressive posterior fossa ependymomaJens-Martin Hübner, Torsten Müller, Dimitris N Papageorgiou, et al.Plos One|May 9, 2015
Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populationsJo Meagan Garner, David W Ellison, David Finkelstein, et al.Acta Neuropathologica|April 25, 2012
Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomasCatherine Godfraind, Joanna M Kaczmarska, Mehmet Kocak, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2002
ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this diseaseRichard J Gilbertson, Lyndsay Bentley, Roberto Hernan, et al.Pageof 68